FOXP3 and neoplasm: RE1-Silencing Transcription Factor corepressor (CoREST) complexes, containing HDAC1 or HDAC2, impede the functionality of FOXP3+Tregs through deacetylation and augment the body’s anti-tumor capacity (132).